×
Ziprasidone in Treatment-Resistant Schizophrenia: A 52-Week, Open-Label Continuation Study PDF
$ 40.00
Ziprasidone in Treatment-Resistant Schizophrenia: A 52-Week, Open-Label Continuation Study PDF quantity
$ 40.00
×
Ethnicity and Diagnosis in Patients With Affective Disorders PDF
$ 40.00
Ethnicity and Diagnosis in Patients With Affective Disorders PDF quantity
$ 40.00
×
Severe Acute Respiratory Syndrome-Related Psychiatric and Posttraumatic Morbidities and Coping Responses in Medical Staff Within a Primary Health Care Setting in Singapore PDF
$ 40.00
Severe Acute Respiratory Syndrome-Related Psychiatric and Posttraumatic Morbidities and Coping Responses in Medical Staff Within a Primary Health Care Setting in Singapore PDF quantity
$ 40.00
×
Divalproex Monotherapy in the Treatment of Bipolar Offspring With Mood and Behavioral Disorders and at Least Mild Affective Symptoms PDF
$ 40.00
Divalproex Monotherapy in the Treatment of Bipolar Offspring With Mood and Behavioral Disorders and at Least Mild Affective Symptoms PDF quantity
$ 40.00
×
Effectiveness of Antipsychotic Therapy in a Naturalistic Setting: A Comparison Between Risperidone, Perphenazine, and Haloperidol PDF
$ 40.00
Effectiveness of Antipsychotic Therapy in a Naturalistic Setting: A Comparison Between Risperidone, Perphenazine, and Haloperidol PDF quantity
$ 40.00
×
Do We Scare Because We Care? PDF
$ 40.00
Do We Scare Because We Care? PDF quantity
$ 40.00
×
A 1-Year Naturalistic Follow-Up of Patients With Compulsive Shopping Disorder PDF
$ 40.00
A 1-Year Naturalistic Follow-Up of Patients With Compulsive Shopping Disorder PDF quantity
$ 40.00
×
The Selective GABA Reuptake Inhibitor Tiagabine for the Treatment of Generalized Anxiety Disorder: Results of a Placebo-Controlled Study PDF
$ 40.00
The Selective GABA Reuptake Inhibitor Tiagabine for the Treatment of Generalized Anxiety Disorder: Results of a Placebo-Controlled Study PDF quantity
$ 40.00
×
Cytochrome P450 2D6 Phenoconversion Is Common in Patients Being Treated for Depression: Implications for Personalized Medicine PDF
$ 40.00
Cytochrome P450 2D6 Phenoconversion Is Common in Patients Being Treated for Depression: Implications for Personalized Medicine PDF quantity
$ 40.00
×
Relationships Between Obsessive-Compulsive Symptomatology and Severity of Psychosis in Schizophrenia: A Systematic Review and Meta-Analysis PDF
$ 40.00
Relationships Between Obsessive-Compulsive Symptomatology and Severity of Psychosis in Schizophrenia: A Systematic Review and Meta-Analysis PDF quantity
$ 40.00
×
Cognitive-Behavioral Management of Patients With Bipolar Disorder Who Relapsed While on Lithium Prophylaxis PDF
$ 40.00
Cognitive-Behavioral Management of Patients With Bipolar Disorder Who Relapsed While on Lithium Prophylaxis PDF quantity
$ 40.00
×
The Relationship of Personality Disorders to Treatment Outcome in Depressed Outpatients PDF
$ 40.00
The Relationship of Personality Disorders to Treatment Outcome in Depressed Outpatients PDF quantity
$ 40.00
×
Differences in Quality of Life Domains and Psychopathologic and Psychosocial Factors in Psychiatric Patients. PDF
$ 40.00
Differences in Quality of Life Domains and Psychopathologic and Psychosocial Factors in Psychiatric Patients. PDF quantity
$ 40.00
×
A Combined Index Using the Mini-Mental State Examination and Lawton Index to Discriminate Between Clinical Dementia Rating Scores of 0.5 and 1: A Development and Validation Study PDF
$ 40.00
A Combined Index Using the Mini-Mental State Examination and Lawton Index to Discriminate Between Clinical Dementia Rating Scores of 0.5 and 1: A Development and Validation Study PDF quantity
$ 40.00
×
Comparison of Risperidone and Olanzapine in the Control of Negative Symptoms of Chronic Schizophrenia and Related Psychotic Disorders in Patients Aged 50 to 65 Years PDF
$ 40.00
Comparison of Risperidone and Olanzapine in the Control of Negative Symptoms of Chronic Schizophrenia and Related Psychotic Disorders in Patients Aged 50 to 65 Years PDF quantity
$ 40.00
×
High-Deductible Health Plans Paired With Health Savings Accounts Increased Medication Cost Burden Among Individuals With Bipolar Disorder PDF
$ 40.00
High-Deductible Health Plans Paired With Health Savings Accounts Increased Medication Cost Burden Among Individuals With Bipolar Disorder PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart